Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

Details

• Alternative Title:
  Antimicrob Resist Infect Control
• Personal Author:
  Garcia-Jeldes, Hector Felipe ; Mitchell, Robyn ; McGeer, Allison ; Rudnick, Wallis ; Amaratunga, Kanchana ; Vallabhaneni, Snigdha ; Lockhart, Shawn R. ; Bharat, Amrita
• Corporate Authors:
  CNISP C. auris Interest GroupAl-RawahiGhadaBrodkinElizabethCharlesMartheComeauJeannetteDavisIanDelportJohanDingleTanis C.DufresnePhilippeEllisChelseyEmbreeJoanneFrenetteCharlesGoldingGeorgeHoangLinda M.HotaSusyKatzKevin C.KibseyPamelaKusJulianne V.LangleyJoanne M.LeeBonita E.LefebvreMarie-AstridLongtinYvesMalejczykKathyMasudShaziaMertzDominikMulveyMichael R.PoutanenSusanPurychDaleRantelidisRajniRichardsonDavidSchwartzIlan S.SmithStephanieTremblayMaxime-AntoineWongTitusYamamuraDeborah
• Description:
  To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.
• Subjects:
  Candida Cross Infection Drug Resistance Risk Factors Short Report
• Source:
  Antimicrob Resist Infect Control. 9
• Pubmed ID:
  32522237
• Pubmed Central ID:
  PMC7288437
• Document Type:
  Journal Article
• Volume:
  9
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:2a01239cc32539fe1956b2037635ff68995a07d1d620adec0e42ef10f1082ff6
• Download URL:
  https://stacks.cdc.gov/view/cdc/92620/cdc_92620_DS1.pdf
• File Type:
  [PDF - 577.96 KB ]